• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico.美国和波多黎各一项杀微生物剂试验中年轻女性的动机与经历。
World J AIDS. 2013 Sep;3(3). doi: 10.4236/wja.2013.33023.
2
Altruism among participants in cancer clinical trials.癌症临床试验参与者中的利他主义。
Clin Trials. 2011 Oct;8(5):616-23. doi: 10.1177/1740774511414444. Epub 2011 Aug 3.
3
Motivations for participating in an HIV vaccine efficacy trial.参与HIV疫苗效力试验的动机。
J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):359-64. doi: 10.1097/01.qai.0000152039.88422.ec.
4
Topical microbicides for prevention of sexually transmitted infections.用于预防性传播感染的局部用杀微生物剂。
Cochrane Database Syst Rev. 2012 Jun 13(6):CD007961. doi: 10.1002/14651858.CD007961.pub2.
5
Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.优化针对女性的艾滋病预防措施:杀微生物剂研究证据综述及引入对性别敏感的杀微生物剂的考量
J Int AIDS Soc. 2015 Dec 21;18(1):20536. doi: 10.7448/IAS.18.1.20536. eCollection 2015.
6
Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.参与 1 期疫苗试验的动机:流感和埃博拉随机对照试验的比较。
Vaccine. 2019 Jan 7;37(2):289-295. doi: 10.1016/j.vaccine.2018.11.014. Epub 2018 Dec 7.
7
Knowledge, Motivations and Concerns about Participation in Breast Cancer Clinical Trials in Puerto Rico.关于参与波多黎各乳腺癌临床试验的知识、动机与担忧
J Health Dispar Res Pract. 2020 Spring;13(1):50-66.
8
Women's willingness to participate in microbicide trials in Northern Thailand.
J Acquir Immune Defic Syndr. 2001 Oct 1;28(2):180-6. doi: 10.1097/00126334-200110010-00011.
9
Assisted Reproductive Technology Surveillance — United States, 2012.辅助生殖技术监测—美国,2012 年。
MMWR Surveill Summ. 2015 Aug 14;64(6):1-29.
10
Assisted Reproductive Technology Surveillance - 
United States, 2013.辅助生殖技术监测报告——美国,2013 年。
MMWR Surveill Summ. 2015 Dec 4;64(11):1-25. doi: 10.15585/mmwr.ss6411a1.

引用本文的文献

1
Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.了解女性参与MTN-003/VOICE(一项依从性较低的2b期HIV预防试验)的动机。
BMC Womens Health. 2019 Jan 25;19(1):18. doi: 10.1186/s12905-019-0713-6.
2
Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana.博茨瓦纳艾滋病毒暴露前预防(PrEP)试验参与者的知识、态度和经历
World J AIDS. 2015 Mar;5(2):10-20. doi: 10.4236/wja.2015.51002. Epub 2015 Feb 12.
3
Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.可溶性免疫介质和阴道细菌影响年轻女性的先天性生殖黏膜抗菌活性。
Am J Reprod Immunol. 2015 Oct;74(4):323-32. doi: 10.1111/aji.12412. Epub 2015 Jun 26.

本文引用的文献

1
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention.解析 HIV 预防的暴露前预防试验结果为何出现分歧。
AIDS. 2012 Apr 24;26(7):F13-9. doi: 10.1097/QAD.0b013e3283522272.
2
HIV microbicides: where are we now?HIV阴道杀菌剂:我们目前进展如何?
Curr HIV Res. 2012 Jan 1;10(1):1-2. doi: 10.2174/157016212799304724.
3
Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.美国和波多黎各年轻女性对杀微生物剂凝胶接受度的差异。
Cult Health Sex. 2012;14(2):151-66. doi: 10.1080/13691058.2011.630099. Epub 2011 Nov 15.
4
Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe.预防性误解作为参与和坚持使用杀微生物剂试验的动机:来自马拉维和津巴布韦的女性参与者和男性伴侣的证据。
AIDS Behav. 2012 Apr;16(3):785-90. doi: 10.1007/s10461-011-0027-7.
5
"Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.“告诉朱莉安娜”:在参与 1 期杀微生物剂研究的不同种族、活跃的年轻女性中,候选杀微生物剂 VivaGel®和两种安慰剂凝胶的可接受性。
AIDS Behav. 2012 Oct;16(7):1761-74. doi: 10.1007/s10461-011-0028-6.
6
Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.有选择性地愿意且有条件地能够:艾滋病毒疫苗试验中处于艾滋病毒感染“高危”的女性的参与。
Vaccine. 2011 Aug 18;29(36):6130-5. doi: 10.1016/j.vaccine.2011.06.064. Epub 2011 Jun 23.
7
Forging convictions: the effects of active participation in a clinical trial.伪造定罪:积极参与临床试验的影响。
Soc Sci Med. 2011 Jun;72(12):2041-8. doi: 10.1016/j.socscimed.2011.04.021. Epub 2011 May 18.
8
Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004).MTN-004 研究:评价 SPL7013 凝胶(VivaGel)阴道用药在性活跃年轻女性中的阴道安全性和可接受性的 1 期随机临床试验。
AIDS. 2011 May 15;25(8):1057-64. doi: 10.1097/QAD.0b013e328346bd3e.
9
What predicts non-retention in microbicide trials?哪些因素可预测杀微生物剂试验中的脱落?
Contemp Clin Trials. 2011 Jul;32(4):512-6. doi: 10.1016/j.cct.2011.03.008. Epub 2011 Mar 5.
10
Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173).利他主义促使人们参与一项治疗性HIV疫苗试验(CTN 173)。
AIDS Care. 2010 Nov;22(11):1403-9. doi: 10.1080/09540121003693522.

美国和波多黎各一项杀微生物剂试验中年轻女性的动机与经历。

The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico.

作者信息

Giguere Rebecca, Zimet Gregory D, Kahn Jessica A, Dolezal Curtis, Leu Cheng-Shiun, Mabragaña Marina, McGowan Ian, Carballo-Diéguez Alex

机构信息

HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute and Columbia University, New York, USA.

出版信息

World J AIDS. 2013 Sep;3(3). doi: 10.4236/wja.2013.33023.

DOI:10.4236/wja.2013.33023
PMID:24324918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3855411/
Abstract

Young women are an important target group in microbicide research, yet little is known about why they participate and stay in microbicide trials. Our study examined motivations for participating in a Phase I microbicide trial among 61 women ages 18 - 24 years in the continental USA and Puerto Rico. We also examined their perspectives on study participation. Participants underwent a semi-structured in-depth interview in which they were asked about factors that motivated enrollment and their experiences while participating. They also completed a Web-based Computer Assisted Self Interview in which they were asked to rate study burden (1 = low to 4 = high). Factors that motivated enrollment were altruism (29%), compensation (17%), a combination of altruism and compensation (37%) and free medical exams (17%). Factors that encouraged participants to stay in the study were study staff (95%), confirmation of good health (41%), and the opportunity to learn about their bodies (17%). Mean ratings of study burden ranged from 1.83 (having to travel to site) to 2.41 (colposcopy), indicating that participants were not highly bothered by visits or procedures. Although Phase I trials require invasive procedures, participants were not highly bothered by them and recognized them as necessary. Good relationships with staff and clear information about how procedures contribute to study goals may encourage participants to remain in trials. Young women may be motivated to enter microbicide trials by stressing the role they will play in discovering better HIV-prevention methods and highlighting the comprehensive preventive exams they will receive.

摘要

年轻女性是杀微生物剂研究中的一个重要目标群体,但对于她们参与并留在杀微生物剂试验的原因却知之甚少。我们的研究调查了美国本土和波多黎各61名年龄在18至24岁之间的女性参与一期杀微生物剂试验的动机。我们还研究了她们对参与研究的看法。参与者接受了半结构化的深入访谈,询问了促使她们报名的因素以及参与期间的经历。她们还完成了一项基于网络的计算机辅助自我访谈,被要求对研究负担进行评分(1 = 低至4 = 高)。促使报名的因素有利他主义(29%)、补偿(17%)、利他主义和补偿的结合(37%)以及免费体检(17%)。鼓励参与者留在研究中的因素有研究人员(95%)、健康状况良好的确认(41%)以及了解自身身体的机会(17%)。研究负担的平均评分范围从1.83(必须前往研究地点)到2.41(阴道镜检查),表明参与者并未因访视或程序而受到很大困扰。尽管一期试验需要侵入性程序,但参与者并未受到很大困扰,并认为这些程序是必要的。与研究人员建立良好关系以及清楚了解程序如何有助于研究目标,可能会鼓励参与者继续参与试验。强调她们在发现更好的艾滋病毒预防方法中所起的作用,并突出她们将接受的全面预防性检查,可能会促使年轻女性参与杀微生物剂试验。